Primary Navigation
Want to create or adapt books like this? Learn more about how Pressbooks supports open publishing practices.
Author: Trent Tucker
Download this book
Book Contents Navigation
1. Zenify Your Presentation example
2. Sign-up for LifeScanner Live Case topic…
3. Turing Pharmaceuticals: a glimpse into controversial drug pricing.
4. Chapter 1 • Presentations
5. Quick Start Guide for Bloomberg® Professional
6. Porter's Five Forces
Amna A., Maham H., Viola H., Rashmi K.
7.
8. SWOT analysis
9. How Graph Misrepresents Data
10. PESTLE Analysis
Louis Gasparini, John Britto, Allan Humphrey, Naheen Imtiaz
11. Visualizing Your Data with Tableau
12. Staying one step ahead of the competition with Porter's Value Chain Analysis
13. Using Statistics Canada and Interpreting Data to Generating Graphs
14. McKinsey 7s Framework
15. Balanced Scorecard
16. Business Case 1 • Funky Genetics Co.
17. 23andMe - Insights into Direct to Consumer Genetic Testing
18. Pond Technologies Inc. - Target Markets
19. TAXA Biotechnologies Inc.: A Genetic Engineering Start-up
20. Edge Therapeutics: Fast-tracking EG-1964 to Market or Not
21. Elservier Case Study
22. GlaxoSmithKline Zika Virus Vaccine: Coverage and Aid through Patient Assistance Programs
23. Qvera: The #1 Interface Engine
24. ETEPLIRSEN: A CONTROVERSIAL APPROVAL
25. KORSUVA: The Decisions Cara Therapeutics INC. made to Potentially Revolutionize Pain and Pruritus Relief
26. How Important is Privacy? – A Case on AncestryDNA
27. Queensland University of Technology: Funding a Golden Opportunity
28. Rebuilding the pipeline: Celgene and Juno Therapeutics
29. Okanagan Specialty Fruits & the Arctic® Apple
30. Therapure Biopharmaceuticals: The Risky Decisions of a Growing Company
31. CRISPR Therapeutics – Novel Use of CRISPR/Cas9 Technique in Disease Therapy
Viola Halder
32. Vertex Pharmaceuticals
33. Pond Technologies Inc. - Target Markets
34. The French Pharmaceutical Giant: A case study of Sanofi
35. VALANX BIOTECH
36. Roche Strategies to Tackle Biosimilar Issue
37. Centocor: Commercializing Monoclonal Antibodies
38. K&N's: A Vertically Integrated Business Approach
39. FDA Crisis for Pfizer: The Impact of an FDA Warning On the Company
40. Micron Waste Technologies: Turning Cannabis to Water
41. Epidermolysis bullosa – Rare Disease and big Business
42. IBM Watson Health: Managing Partnerships to Improve Personalized Medicine
43. Big Pharma and Biotech: A match made in heaven?
44. What went wrong with Theranos?
45. Ablexis LCC
46. Aleafia Health Inc.: A Novel Approach in Medical Cannabis
47. Helix: Stocking the Shelves in their Genetic Testing App Store
48. Medtronic: PETA and Public Pushback
49. ROAD SALT ADDICTION
Appendix
Cases and Tools in Biotechnology Management Copyright © by Trent Tucker. All Rights Reserved.
